We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 3,475

Commission Holds Section 337 Oral Argument
  • Jones Day
  • USA
  • November 22 2016

Following up on our previous post, on November 17th, the ITC held an oral argument in front of a packed hearing room in Certain Lithium Metal Oxide


Food, Dietary Supplement & Cosmetics Regulatory Update Vol. III, Issue 15
  • Jones Day
  • European Union, USA
  • November 19 2016

This month, in the middle of the renewal period for registration of food facilities, FDA has published the seventh edition of its draft guidance


PTAB Hand Slapped for Overeager Exclusion of Reg Synthetic Evidence
  • Jones Day
  • USA
  • November 18 2016

On Nov. 8, the Federal Circuit reversed a PTAB decision to exclude certain allegedly hearsay Reg Synthetic evidence submitted in an attempt to


Energy and Environmental Ramifications of the Trump Election
  • Jones Day
  • USA
  • November 17 2016

Significant changes to U.S. energy and environmental policies are likely to occur in the presidential administration of Donald J. Trump


Judge Gilstrap Denies Motion to Stay Because Defendant Relying on Third Party IPR Would Not Agree to be Fully Bound by Statutory Estoppel of 35 U.S.C. 315
  • Jones Day
  • USA
  • November 17 2016

In Intellectual Ventures II LLC v. Kemper Corporation (accessible here), No. 6:16-cv-00081, Dkt No. 57 (E.D. Tex. Nov. 7, 2016) (Slip Op.), Judge


Federal Banking Agencies Propose Enhanced Cyber Risk Management Standards
  • Jones Day
  • USA
  • November 16 2016

The Board of Governors of the Federal Reserve System ("Federal Reserve Board"), the Federal Deposit Insurance Corporation, and the Office of the


The Future of the Affordable Care Act
  • Jones Day
  • USA
  • November 16 2016

President-elect Trump has made revamping our health care system a top priority for his new administration. He has been clear that action needs to be


Fed. Circuit Rules that Parties Must Have Opportunity to RespondRebut Late-Made Factual Assertions
  • Jones Day
  • USA
  • November 14 2016

The Federal Circuit vacated the Patent Trial and Appeal Board’s decision in IPR2013-508 after finding that its refusal to allow NuVasive, the patent


OUII Recommends Narrow Scope for Advisory Opinion
  • Jones Day
  • USA
  • November 11 2016

Under 19 C.F.R. 210.79, the ITC can issue an Advisory Opinion “as to whether a person’s proposed course of action or conduct would violate a


PTAB Upholds Patent Claims on Methods of Using Ravicti
  • Jones Day
  • USA
  • November 11 2016

On November 3, 2016, the PTAB issued a Final Written Decision upholding a Horizon Therapeutics LLC (“Horizon”) patent, U.S. 8,642,012 (the ’012